• SIS3: Reading TGF-β/Smad3 Signaling in Context

  2026-09-07

  SIS3 is a selective Smad3 inhibitor for separating canonical TGF-β signaling from downstream phenotype. This article connects SIS3 assay design with super-enhancer-driven lung adenocarcinoma, fibrosis research, and translational model interpretation.

• Miltefosine: A Two-Pathway Research Framework

  2026-09-07

  Miltefosine is more than a PI3K/Akt pathway inhibitor: new evidence links it to Ras/MEK/ERK-driven neutrophil differentiation. This article translates the findings into practical assay, pathway-selection, and translational research decisions.

• PTT and CD47 Blockade in Oral Cancer

  2026-09-05

  This study shows that photothermal therapy (PTT) can overcome two barriers that limit CD47 blockade in oral squamous cell carcinoma: the absence of a macrophage-activating “eat me” signal and poor immune-cell access through the tumor extracellular matrix. By inducing calreticulin exposure, damage-associated molecular patterns, and extracellular matrix remodeling, PTT substantially improved macrophage phagocytosis and tumor growth control in the reported models.

• Fangchinoline Restores TFEB-Driven Lysosomal Defense

  2026-09-04

  The reference study identifies fangchinoline as a host-directed antiviral compound that restores TFEB-associated lysosomal biogenesis and interferes with H1N1 entry. Its integrated screening, lysosomal phenotyping, autophagy analysis, and time-resolved infection assays provide a mechanistic framework for targeting virus-induced lysosomal dysfunction.

• Safe DNA Gel Stain for Safer Gel Workflows

  2026-09-04

  Safe DNA Gel Stain supports sensitive DNA and RNA visualization while reducing reliance on ethidium bromide and damaging UV exposure. Its blue-light-compatible workflow is especially useful for wheat genotyping, gel extraction, cloning, and routine molecular biology nucleic acid detection.

• Regulatory NADH/NAD+ Biosensor for Bacteria

  2026-09-03

  The reference study developed a Rex-based genetically encoded biosensor that converts bacterial NADH/NAD+ redox changes into a ratiometric fluorescent signal. Its application to respiratory-chain mutants, carbon-source comparisons, and pooled enrichment demonstrates how regulatory biosensors can support noninvasive, higher-throughput analysis of bacterial metabolism.

• Fangchinoline, TFEB, and H1N1 Lysosomal Defense

  2026-09-03

  Cheng et al. identify fangchinoline as a lysosome-targeting compound that activates TFEB, restores lysosomal biogenesis, and restricts H1N1 infection. The study combines Connectivity Map screening, transcriptomic analysis, cellular trafficking assays, and in vivo validation to support a host-directed antiviral mechanism centered on endolysosomal entry.

• Linoleic Acid (C18:2) Protocol and QC Guide

  2026-09-02

  Linoleic Acid (SKU C3108) supports controlled studies of membrane behavior, oxidative stress, erythrocyte injury, cell migration, and essential fatty acid deficiency. Because it is water-insoluble and supplied as an oily liquid, it should be handled through freshly prepared ethanol or DMSO stocks rather than long-term aqueous solutions.

• L-Glutathione Reduced: Redox and GST Workflows

  2026-09-02

  L-Glutathione Reduced supports two distinct research use cases: controlled redox perturbation in cancer-metabolism experiments and competitive elution of GST-tagged proteins. Its practical value is greatest when fresh aqueous preparation, oxidation controls, and orthogonal readouts are built into the workflow.

• Cyclosporin A: Mechanism-to-Assay Design Guide

  2026-09-01

  Cyclosporin A is more than an immunosuppressive reagent: its cyclophilin–calcineurin biology can determine how apoptosis, mitochondrial, and inflammatory assays should be designed. This guide also translates lessons from a luteolin delivery study into practical decisions about controls, formulation, and interpretation.

• V5 Epitope Tag Peptide: Workflow & Troubleshooting

  2026-09-01

  The V5 Epitope Tag Peptide supports sequence-specific controls for recombinant protein expression, Western blotting, immunoprecipitation, and antibody screening. This guide turns the GKPIPNPLLGLDST peptide into a practical calibration and troubleshooting reagent, while distinguishing established immunoassays from emerging single-molecule workflows.

• SCH772984 HCl: ERK1/2 Inhibitor Workflows

  2026-08-31

  SCH772984 HCl provides a direct way to interrogate ERK1/2 signaling, from acute substrate-phosphorylation assays to longer-term viability and resistance models. This workflow-focused guide also shows how ERK perturbation can be paired with TERT, telomerase, and APEX2 assays without overstating what current evidence proves.

• Mitomycin C for Cell-Death Assay Design

  2026-08-31

  Mitomycin C is more than an antitumor antibiotic: it is a powerful perturbation tool for connecting DNA replication inhibition with measurable cell-death phenotypes. This guide translates liver cell-death biology into a rigorous assay-design framework for cancer research, colon cancer models, and apoptosis signaling research.

• 2-APB Workflows for Calcium Signaling Research

  2026-08-30

  Build reproducible calcium-release and channel-modulation assays with 2-APB, from concentration screening to ER-versus-plasma-membrane pathway separation. The guide also shows how to use this calcium signaling inhibitor alongside the PLCβ3-focused findings of a cardiovascular study without confusing functional pathway blockade with direct target engagement.

• Gly-Gly-Phe-Gly (GGFG) Peptide Workflow

  2026-08-29

  Learn how to use Gly-Gly-Phe-Gly as a flexible peptide linker in drug conjugation research, antibody-drug conjugate development, and biomaterial construction. This workflow connects practical GGFG handling with assay design inspired by panobinostat research in MLL-rearranged leukemia, while clearly separating established evidence from application-specific recommendations.

8023 records 1/535 page Next 12345 下5页 Last page